KL, G., S, S., N, L., F, B., R, F., Y, N., . . . M, L. (2024). Discovery of Clinical Candidate AZD5462, a Selective Oral Allosteric RXFP1 Agonist for Treatment of Heart Failure. Journal of medicinal chemistry, 67(6), 4419. https://doi.org/10.1021/acs.jmedchem.3c02184
Chicago Style (17th ed.) CitationKL, Granberg, et al. "Discovery of Clinical Candidate AZD5462, a Selective Oral Allosteric RXFP1 Agonist for Treatment of Heart Failure." Journal of Medicinal Chemistry 67, no. 6 (2024): 4419. https://doi.org/10.1021/acs.jmedchem.3c02184.
MLA (9th ed.) CitationKL, Granberg, et al. "Discovery of Clinical Candidate AZD5462, a Selective Oral Allosteric RXFP1 Agonist for Treatment of Heart Failure." Journal of Medicinal Chemistry, vol. 67, no. 6, 2024, p. 4419, https://doi.org/10.1021/acs.jmedchem.3c02184.